Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Alison M. Friedmann"'
Autor:
Diana W. Bartenstein, BA, Taylor M. Coe, MD, Samantha C. Gordon, MD, Alison M. Friedmann, MD, Maryanne M. Senna, MD, Cassandra M. Kelleher, MD, Cristina R. Antonescu, MD, Rosalynn M. Nazarian, MD, Elena B. Hawryluk, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 4, Iss 2, Pp 185-188 (2018)
A 14-month-old boy presented with a slow-growing, asymptomatic back plaque, which was biopsied and found to have S100 positivity, sparse CD34 staining, and no significant mitotic activity, nuclear pleomorphism, or necrosis; genetic workup found LMNA-
Externí odkaz:
https://doaj.org/article/7b752e50933d4927a2892e2db0f75193
Pediatric Acute Promyelocytic Leukemia Presenting to the Emergency Department as Refusal to Ambulate
Publikováno v:
Case Reports in Emergency Medicine, Vol 2018 (2018)
A previously healthy 10-year-old girl presented to the emergency department (ED) with a headache and vomiting which resolved with oral NSAIDs. The patient returned two days later unable to ambulate with mental slowing and lower extremity bruising. La
Externí odkaz:
https://doaj.org/article/9525693a8465411f9a8af832698b3ef9
Autor:
Belinda N. Mandrell, Alison M. Friedmann, Barry L. Shulkin, Monika L. Metzger, Matthew J. Krasin, Sandra Luna-Fineman, John T. Lucas, Sue C. Kaste, Susan M. Hiniker, Jamie E. Flerlage, Chen Li, Amy L. Billett, Nickhill Bhakta, Matthew J. Ehrhardt, Eric Larsen, Michael P. Link, Melissa M. Hudson, Torunn I. Yock, Pedro A. de Alarcon, Zhaohua Lu, Sarah S. Donaldson
Publikováno v:
J Clin Oncol
PURPOSE Brentuximab vedotin, an effective anti-CD30 antibody-drug conjugate approved for use in adults with classical Hodgkin lymphoma (HL), was introduced in this frontline trial to reduce prescribed radiation in children and adolescents with classi
Autor:
Mignon L. Loh, Alison M. Friedmann, David T. Marshall, Nyla A. Heerema, Leonard A. Mattano, Naomi J. Winick, Cindy Wang, Julie M. Gastier-Foster, William L. Carroll, Meenakshi Devidas, Kelly W. Maloney, Andrew J. Carroll, Stephen P. Hunger, Nina S. Kadan-Lottick, Patrick J. Buckley, Michael J. Borowitz, Brent L. Wood, Yousif Matloub, Elizabeth A. Raetz, Linda C. Stork
Publikováno v:
Journal of Clinical Oncology. 39:1540-1552
PURPOSE Children's Oncology Group (COG) AALL0331 tested whether pegaspargase intensification on a low-intensity chemotherapy backbone would improve the continuous complete remission (CCR) rate in a low-risk subset of children with standard-risk B-acu
Autor:
Jonathan Keith Killian, Sam Sadigh, Alison M. Friedmann, Chelsea Marcus, Valentina Nardi, Wesley R Samore, Erik A. Williams, Joseph Giessinger, Kathleen Foley-Peres, Shakti H. Ramkissoon, Riza R. Milante, Abner Louissaint, Eric Allan Severson, Daniel Duncan, Yin P Hung, Lucas R. Massoth, Lawrence R. Zukerberg, G. Petur Nielsen, Smruthy Sivakumar, Robert P. Hasserjian, Martin K. Selig, Jo-Anne Vergilio, Vinayak Venkataraman, Vikram Desphande, Judith A. Ferry, Jeffrey S. Ross
Publikováno v:
The Oncologist
Background Histiocytic and dendritic cell neoplasms are a diverse group of tumors arising from monocytic or dendritic cell lineage. Whereas the genomic features for Langerhans cell histiocytosis and Erdheim‐Chester disease have been well described,
Autor:
Alison M. Friedmann, Konstantinos Papamichael, Meghan E. Gibson, Jason Shapiro, Sonia Friedman, Adam S. Cheifetz, Rachel W. Winter, Matthew J. Hamilton, Diana O. Treaba, Timothy Menz, Alejandro Llanos-Chea, Harland S. Winter, Logan Jerger
Publikováno v:
Digestive Diseases and Sciences. 67:252-258
Inflammatory bowel diseases (IBD) are often treated with anti-tumor necrosis factor alpha (anti-TNFα) medications. Concomitant treatment of IBD with anti-TNFα agents and immunomodulators appears to be associated with an increased risk for lymphoma.
Autor:
William L. Carroll, Julie M. Gastier-Foster, Nina S. Kadan-Lottick, Patrick J. Buckley, Michael J. Borowitz, Kelly W. Maloney, Elizabeth A. Raetz, Stephen P. Hunger, Linda C. Stork, Alison M. Friedmann, Cindy Wang, Meenakshi Devidas, David T. Marshall, Brent L. Wood, Andrew J. Carroll, Yousif Matloub, Mignon L. Loh, Naomi J. Winick, Nyla A. Heerema, Leonard A. Mattano
Publikováno v:
J Clin Oncol
PURPOSE Children’s Oncology Group (COG) AALL0331 tested whether intensified postinduction therapy that improves survival in children with high-risk B-cell acute lymphoblastic leukemia (ALL) would also improve outcomes for those with standard-risk (
Publikováno v:
New England Journal of Medicine. 381:1763-1772
A Boy with Jaundice A 16-year-old boy was admitted to the hospital in autumn because of malaise, abdominal cramping, and jaundice. Ultrasonography of the abdomen revealed splenomegaly. Atypical lym...
Publikováno v:
Pediatric Blood & Cancer. 68
Publikováno v:
Pediatric bloodcancer. 68(10)